• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫苗对经济活动的影响。

The effects of COVID-19 vaccines on economic activity.

作者信息

Deb Pragyan, Furceri Davide, Jimenez Daniel, Kothari Siddharth, Ostry Jonathan D, Tawk Nour

机构信息

International Monetary Fund, Washington, DC 20431 USA.

Centre for Economic Policy Research, London, UK.

出版信息

Swiss J Econ Stat. 2022;158(1):3. doi: 10.1186/s41937-021-00082-0. Epub 2022 Jan 12.

DOI:10.1186/s41937-021-00082-0
PMID:35036364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753340/
Abstract

This paper empirically examines the economic effects of COVID-19 vaccine rollouts using a cross-country daily database of vaccinations and high-frequency indicators of economic activity-nitrogen dioxide (NO) emissions, carbon monoxide (CO) emissions, and Google mobility indices-for a sample of 46 countries over the period December 16, 2020 to June 20, 2021. Using surprises in vaccines administered, we find that an unexpected increase in vaccination per capita is associated with a significant increase in economic activity. We also find evidence for nonlinear effects of vaccines, with the marginal economic benefits being larger when vaccination rates are higher. Country-specific conditions play an important role, with lower economic gains if strict containment measures are in place or if the country is experiencing a severe outbreak. Finally, the results provide evidence of spillovers across borders, highlighting the importance of equitable access to vaccines across nations.

摘要

本文利用一个涵盖46个国家、时间跨度为2020年12月16日至2021年6月20日的跨国每日疫苗接种数据库以及经济活动高频指标(二氧化氮(NO)排放量、一氧化碳(CO)排放量和谷歌移动指数),对新冠疫苗推出的经济影响进行了实证研究。通过疫苗接种量的意外变化,我们发现人均疫苗接种量的意外增加与经济活动的显著增加相关。我们还发现了疫苗的非线性效应证据,即接种率较高时边际经济收益更大。国家特定条件起着重要作用,若实施严格的防控措施或国家正经历严重疫情爆发,则经济收益较低。最后,研究结果提供了跨境溢出效应的证据,凸显了各国公平获得疫苗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/cf06c1e12562/41937_2021_82_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/d21fb0f059b1/41937_2021_82_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/dc6eae75aa60/41937_2021_82_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/55276a5ef7f7/41937_2021_82_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/a3252712fb73/41937_2021_82_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/a2c9770796fa/41937_2021_82_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/9e5dd47635e5/41937_2021_82_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/424c4a9a9a52/41937_2021_82_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/cf06c1e12562/41937_2021_82_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/d21fb0f059b1/41937_2021_82_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/dc6eae75aa60/41937_2021_82_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/55276a5ef7f7/41937_2021_82_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/a3252712fb73/41937_2021_82_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/a2c9770796fa/41937_2021_82_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/9e5dd47635e5/41937_2021_82_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/424c4a9a9a52/41937_2021_82_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3022/8753340/cf06c1e12562/41937_2021_82_Fig8_HTML.jpg

相似文献

1
The effects of COVID-19 vaccines on economic activity.新冠疫苗对经济活动的影响。
Swiss J Econ Stat. 2022;158(1):3. doi: 10.1186/s41937-021-00082-0. Epub 2022 Jan 12.
2
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes.新冠病毒疫苗推广的决定因素及其对健康结果的影响。
Appl Health Econ Health Policy. 2023 Jan;21(1):71-89. doi: 10.1007/s40258-022-00757-6. Epub 2022 Sep 14.
3
Testing the Club Convergence Dynamics of the COVID-19 Vaccination Rates Across the OECD Countries.检测经合组织国家 COVID-19 疫苗接种率的俱乐部趋同动态。
Front Public Health. 2022 May 6;10:872561. doi: 10.3389/fpubh.2022.872561. eCollection 2022.
4
The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.新冠疫苗在中低收入国家延迟接种的影响。
Front Public Health. 2023 Jan 12;10:1087138. doi: 10.3389/fpubh.2022.1087138. eCollection 2022.
5
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.评估 2020 年 1 月 1 日至 2022 年 7 月 31 日美国各州的 COVID-19 大流行政策和行为及其经济和教育方面的权衡取舍:一项观察性分析。
Lancet. 2023 Apr 22;401(10385):1341-1360. doi: 10.1016/S0140-6736(23)00461-0. Epub 2023 Mar 23.
6
Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.跨国证据表明,国家治理在推动 COVID-19 疫苗接种方面发挥了作用。
BMC Public Health. 2022 Mar 23;22(1):576. doi: 10.1186/s12889-022-12985-5.
7
Lockdown spillovers.封锁的外溢效应。
J Int Money Finance. 2023 Oct;137:102890. doi: 10.1016/j.jimonfin.2023.102890. Epub 2023 Jun 12.
8
Measuring income-associated inequalities in COVID-19 vaccination on a global scale: a modeling study.衡量全球范围内 COVID-19 疫苗接种中与收入相关的不平等:一项建模研究。
J Public Health Policy. 2023 Sep;44(3):449-463. doi: 10.1057/s41271-023-00433-6. Epub 2023 Aug 21.
9
Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.评估新冠疫苗接种策略项目中的不平等现象:一项使用机器学习方法的跨国研究
Vaccines (Basel). 2022 Jan 26;10(2):194. doi: 10.3390/vaccines10020194.
10
COVID-19 case doubling time associated with non-pharmaceutical interventions and vaccination: A global experience.COVID-19 病例倍增时间与非药物干预和疫苗接种的关系:全球经验。
J Glob Health. 2021 Sep 4;11:05021. doi: 10.7189/jogh.11.05021. eCollection 2021.

引用本文的文献

1
A comparative analysis of the role of containment policies, vaccination strategies and virus variants in the COVID-19 pandemic across nine European countries.九个欧洲国家在新冠疫情中遏制政策、疫苗接种策略及病毒变体作用的比较分析
Sci Rep. 2025 Aug 8;15(1):29109. doi: 10.1038/s41598-025-10132-9.
2
COVID-19 vaccine uptake in individuals with functional difficulty, disability, and comorbid conditions: insights from a national survey in Bangladesh.功能障碍、残疾和合并症个体的 COVID-19 疫苗接种率:来自孟加拉国全国调查的见解。
BMC Public Health. 2024 Sep 17;24(1):2531. doi: 10.1186/s12889-024-20096-6.
3
New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement.

本文引用的文献

1
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes.新冠病毒疫苗推广的决定因素及其对健康结果的影响。
Appl Health Econ Health Policy. 2023 Jan;21(1):71-89. doi: 10.1007/s40258-022-00757-6. Epub 2022 Sep 14.
2
Tracking the COVID-19 crisis with high-resolution transaction data.利用高分辨率交易数据追踪新冠疫情危机
R Soc Open Sci. 2021 Aug 11;8(8):210218. doi: 10.1098/rsos.210218. eCollection 2021 Aug.
3
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
新型疫苗平台——经济与社会价值的新维度及其衡量
Vaccines (Basel). 2024 Feb 24;12(3):234. doi: 10.3390/vaccines12030234.
4
Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis.量化加拿大人群中与新冠病毒疫苗接种相关的经济收益:成本效益分析。
Can Commun Dis Rep. 2023 Jun 1;49(6):263-273. doi: 10.14745/ccdr.v49i06a03.
5
Causes and costs of global COVID-19 vaccine inequity.全球 COVID-19 疫苗不平等的原因和代价。
Semin Immunopathol. 2024 Jan;45(4-6):469-480. doi: 10.1007/s00281-023-00998-0. Epub 2023 Oct 23.
6
Do COVID-19 pandemic-related policy shocks flatten the bid-rent curve? Evidence from real estate markets in Shanghai.与新冠疫情相关的政策冲击会使竞租曲线趋于平缓吗?来自上海房地产市场的证据。
J Hous Built Environ. 2023 Apr 28:1-19. doi: 10.1007/s10901-023-10033-1.
7
A retrospective cohort study of incidence and risk factors for severe SARS-CoV-2 breakthrough infection among fully vaccinated people.一项回顾性队列研究,评估完全接种疫苗人群中严重 SARS-CoV-2 突破感染的发生率和危险因素。
Sci Rep. 2023 May 26;13(1):8531. doi: 10.1038/s41598-023-35591-w.
8
The COVID-19 shock and consumer credit: Evidence from credit card data.新冠疫情冲击与消费者信贷:来自信用卡数据的证据
J Bank Financ. 2023 Jul;152:106854. doi: 10.1016/j.jbankfin.2023.106854. Epub 2023 Apr 23.
9
The impact of the COVID-19 pandemic on global GDP growth.新冠疫情对全球国内生产总值增长的影响。
J Jpn Int Econ. 2023 Jun;68:101258. doi: 10.1016/j.jjie.2023.101258. Epub 2023 Mar 22.
10
Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence.2019冠状病毒病疫苗接种活动的增量净效益和增量成本效益比:成本效益证据的系统评价
Vaccines (Basel). 2023 Feb 3;11(2):347. doi: 10.3390/vaccines11020347.
英国新冠病毒疫苗接种与保持社交距离相结合的潜在健康和经济价值:基于传播模型的未来情景分析与经济评估
Lancet Infect Dis. 2021 Jul;21(7):962-974. doi: 10.1016/S1473-3099(21)00079-7. Epub 2021 Mar 18.
4
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
5
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.